TuHURA Biosciences, Inc. (HURA) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -4.41M | -5.56M | -11.09M | -6.25M | -4.74M | -2.6M | -1.89M | -3.83M | -2.12M | 0 | -1.51M | -3.23M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 6.87% | -113.72% | -486.9% | - | -23.58% | -22.8% | - | -18.6% | 2.04% | 100% | 69.79% | - |
| Net Income | -7.54M | -6.76M | -7.1M | -9.52M | -6.66M | -6M | -2.16M | -4.84M | -1.02M | -4.54K | -3.33M | -18.71M |
| Depreciation & Amortization | 23.47K | 22.54K | 21.29K | 13.37K | 14.06K | 17.64K | 29K | 8K | 15K | 0 | 15K | 60.45K |
| Stock-Based Compensation | 0 | 1.96M | 1.63M | 1.41M | 1.42M | 0 | 101K | 334.6K | 0 | 0 | 0 | 169.65K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 2.8M | -1.24M | 315.66K | 0 | 0 | 1.25M | -10K | 1.17M | 215K | 4.54K | 1.36M | 16.2M |
| Working Capital Changes | 303.93K | 460.47K | -5.95M | 1.86M | 487.15K | 2.13M | 152K | -508K | -1.32M | 0 | 453K | -953.95K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 452.01K | 0 | 0 | 0 | 445.54K | 2.4M | 0 | 0 | -1.28M | 0 | 174K | 0 |
| Cash from Investing | -48.85K | -27.85K | 0 | -156.46K | -1.15M | -823.54K | 0 | 0 | -20K | 0 | 0 | -1.2M |
| Capital Expenditures | -48.85K | -27.85K | 0 | -5.56K | -42.67K | -21.41K | 0 | 0 | -20K | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | -1.11M | 0 | 0 | 0 | 0 | 0 | 0 | -1.2M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | -150.9K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 7.14M | 6.51M | 5.27M | 8.7M | -547.88K | -3.52M | 0 | 4.63M | 2.58M | 0 | -2K | 0 |
| Debt Issued (Net) | -208.2K | 1.19M | -576.35K | 0 | 0 | -5.13K | 27.46M | 4.9M | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 7.35M | 6.19M | 6.2M | 3.12M | 4.21K | 916.02K | 0 | 0 | 2.58M | 0 | 43K | 0 |
| Dividends Paid | -2.09K | -2.09K | -2.09K | -2.09K | -2.09K | 0 | 0 | -2K | -2K | 0 | -2K | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -875.97K | -347.97K | 5.58M | -550K | -4.43M | 0 | -270.3K | 0 | 0 | -43K | 0 |
| Net Change in Cash | 2.68M | 922.53K | -5.82M | 2.29M | -6.44M | 0 | -1.89M | 796.46K | 0 | 0 | 0 | -4.43M |
| Free Cash Flow | -4.46M | -5.58M | -11.09M | -6.25M | -4.78M | -2.62M | -1.89M | -3.83M | -2.14M | 0 | -1.51M | -3.23M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 6.68% | -113.04% | -486.9% | - | -24.69% | -22.65% | - | -18.6% | 1.11% | 100% | 69.79% | - |
| FCF per Share | -0.07 | -0.12 | -0.22 | -0.14 | -0.11 | -0.06 | -0.87 | -11.02 | -17.25 | - | -31.19 | -67.31 |
| FCF Conversion (FCF/Net Income) | 0.59x | 0.82x | 1.56x | 0.66x | 0.71x | 0.43x | 0.34x | 0.79x | 2.07x | - | 0.45x | 0.99x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |